WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced that it was added to the Russell 2000® Index and thus the broad-market Russell 3000® Index when the indexes reconstituted at market close on June 26, 2015. “We are excited to be added to the Russell 2000 Index, which comprises some of the most recognizable companies and serves as a benchmark for small-cap stocks in the United States,” said Scott Tarriff, President and Chief Executive Officer of Eagl
| < Prev | Next > |
|---|
